Schipani, M.; Bellia, M.; Sella, C.; Dondolin, R.; Greco, M.; Mahmoud, A.M.; Deambrogi, C.; Moia, R.; Gaidano, G.; Bruna, R.
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy. Cancers 2025, 17, 3258.
https://doi.org/10.3390/cancers17193258
AMA Style
Schipani M, Bellia M, Sella C, Dondolin R, Greco M, Mahmoud AM, Deambrogi C, Moia R, Gaidano G, Bruna R.
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy. Cancers. 2025; 17(19):3258.
https://doi.org/10.3390/cancers17193258
Chicago/Turabian Style
Schipani, Mattia, Matteo Bellia, Carola Sella, Riccardo Dondolin, Mariangela Greco, Abdurraouf Mokhtar Mahmoud, Clara Deambrogi, Riccardo Moia, Gianluca Gaidano, and Riccardo Bruna.
2025. "Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy" Cancers 17, no. 19: 3258.
https://doi.org/10.3390/cancers17193258
APA Style
Schipani, M., Bellia, M., Sella, C., Dondolin, R., Greco, M., Mahmoud, A. M., Deambrogi, C., Moia, R., Gaidano, G., & Bruna, R.
(2025). Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy. Cancers, 17(19), 3258.
https://doi.org/10.3390/cancers17193258
